Study identifier:D3250R00124
ClinicalTrials.gov identifier:NCT06422078
EudraCT identifier:N/A
CTIS identifier:N/A
A non-interventional, prospective study with benralizumab to investigate clinical outcome based on standard of care medication in real-life
ASTHMA, BRONCHIAL
N/A
No
-
All
300
Observational
18 Years - 120 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
None
No locations available
Arms | Assigned Interventions |
---|